Global Recombinant Human Serum Albumin Market Professional Survey Report 2024
The global Recombinant Human Serum Albumin market was valued at US$ 69.55 million in 2021, will reach US$ 114.1 million by the end of 2034, growing at a CAGR of 7.28% during 2024-2034.
This report focuses on Recombinant Human Serum Albumin volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Recombinant Human Serum Albumin market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Human Serum Albumin in North America, Europe, China, India, etc.
For the manufacturers covered, this report analyzes the Recombinant Human Serum Albumin manufacturing sites, capacity, production, ex-factory price, revenue and market share for each company.
By Company
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
Segment by Type
OsrHSA
ScrHSA
Segment by Application
Cell Culture Media
Medical Supplements
Other
By Region
North America
Europe
China
India
Japan
Southeast Asia
Table of Content
1 Industry Overview of Recombinant Human Serum Albumin 1
1.1 Definition of Recombinant Human Serum Albumin 1
1.2 Recombinant Human Serum Albumin Segment by Type 1
1.2.1 Global Recombinant Human Serum Albumin Production Growth Rate Comparison by Type (2024-2034) 2
1.2.2 OsrHSA 3
1.2.3 ScrHSA 4
1.3 Recombinant Human Serum Albumin Segment by Application 5
1.3.1 Global Recombinant Human Serum Albumin Consumption Comparison by Application (2024-2034) 5
1.3.2 Cell Culture Media 6
1.3.3 Medical Supplements 7
1.4 Recombinant Human Serum Albumin Overall Market: 2017 VS 2021 VS 2034 8
1.4.1 Global Recombinant Human Serum Albumin Revenue (2017-2034) 9
1.4.2 Global Recombinant Human Serum Albumin Production (2017-2034) 11
1.4.3 North America Recombinant Human Serum Albumin Status and Prospect (2017-2034) 12
1.4.4 Europe Recombinant Human Serum Albumin Status and Prospect (2017-2034) 13
1.4.5 China Recombinant Human Serum Albumin Status and Prospect (2017-2034) 14
1.4.6 India Recombinant Human Serum Albumin Status and Prospect (2017-2034) 15
2 Manufacturing Cost Structure Analysis 16
2.1 Raw Material and Suppliers 16
2.2 Manufacturing Cost Structure Analysis of Recombinant Human Serum Albumin 18
2.3 Manufacturing Process Analysis of Recombinant Human Serum Albumin 19
2.4 Industry Chain Structure of Recombinant Human Serum Albumin 20
3 Development and Manufacturing Plants Analysis of Recombinant Human Serum Albumin 21
3.1 Top Manufacturers Headquarters, Rank by Recombinant Human Serum Albumin Production 21
3.2 Global Recombinant Human Serum Albumin Manufacturing Plants Distribution and Founded Date 21
3.3 Major Manufacturers Recombinant Human Serum Albumin Product Offered 22
3.4 Recent Development and Expansion Plans 22
4 Key Figures of Major Manufacturers 25
4.1 Global Top Manufacturers Recombinant Human Serum Albumin Production Analysis 25
4.2 Global Top Manufacturers Recombinant Human Serum Albumin Revenue Analysis 27
4.3 Global Recombinant Human Serum Albumin by Company Type (Tier 1, Tier 2, and Tier 3) 29
4.4 Global Top Manufacturers Recombinant Human Serum Albumin Price Analysis 29
4.5 Market Concentration Degree 30
5 Recombinant Human Serum Albumin Regional Market Analysis 32
5.1 Recombinant Human Serum Albumin Market Size by Regions (2017-2024) 32
5.1.1 Global Recombinant Human Serum Albumin Production by Regions (2017-2024) 32
5.1.2 Global Recombinant Human Serum Albumin Revenue by Regions (2017-2024) 33
5.2 Recombinant Human Serum Albumin Market Size by Regions (2023-2034) 34
5.2.1 Global Recombinant Human Serum Albumin Production by Regions (2023-2034) 34
5.2.2 Global Recombinant Human Serum Albumin Revenue by Regions (2023-2034) 35
5.3 Recombinant Human Serum Albumin Consumption by Regions 36
5.3.1 Recombinant Human Serum Albumin Consumption by Regions (2017-2024) 36
5.3.2 Recombinant Human Serum Albumin Consumption by Regions (2023-2034) 37
5.4 North America Recombinant Human Serum Albumin Market Analysis 39
5.4.1 Key Manufacturers in North America 39
5.4.2 North America Recombinant Human Serum Albumin Consumption 39
5.5 Europe Recombinant Human Serum Albumin Market Analysis 40
5.5.1 Key Manufacturers in Europe 40
5.5.2 Europe Recombinant Human Serum Albumin Consumption 40
5.6 Japan Recombinant Human Serum Albumin Market Analysis 41
5.6.1 Key Manufacturers in Japan 41
5.6.2 Japan Recombinant Human Serum Albumin Consumption 41
5.7 China Recombinant Human Serum Albumin Market Analysis 42
5.7.1 Key Manufacturers in China 42
5.7.2 China Recombinant Human Serum Albumin Consumption 42
5.8 India Recombinant Human Serum Albumin Market Analysis 43
5.8.1 Key Manufacturers in India 43
5.8.2 India Recombinant Human Serum Albumin Consumption 43
5.9 Southeast Asia Recombinant Human Serum Albumin Market Analysis 44
5.9.1 Key Manufacturers in Southeast Asia 44
5.9.2 Southeast Asia Recombinant Human Serum Albumin Consumption 44
6 Recombinant Human Serum Albumin Segment Market Analysis (by Type) 45
6.1 Global Recombinant Human Serum Albumin Market Size by Type (2017-2024) 45
6.1.1 Global Recombinant Human Serum Albumin Production by Type (2017-2024) 45
6.1.2 Global Recombinant Human Serum Albumin Revenue by Type (2017-2024) 46
6.2 Global Recombinant Human Serum Albumin Market Size by Type (2023-2034) 47
6.2.1 Global Recombinant Human Serum Albumin Production by Type (2023-2034) 47
6.2.2 Global Recombinant Human Serum Albumin Revenue by Type (2023-2034) 48
6.3 Recombinant Human Serum Albumin Price by Type 48
7 Recombinant Human Serum Albumin Segment Market Analysis (by Application) 50
7.1 Overview 50
7.2 Global Recombinant Human Serum Albumin Consumption Market Share by Application (2017-2024) 50
7.3 Global Recombinant Human Serum Albumin Consumption Market Share by Application (2023-2034) 52
8 Key Company Profiles 53
8.1 Albumedix 53
8.1.1 Albumedix Corporation Information 53
8.1.2 Albumedix Recombinant Human Serum Albumin Products Offered 54
8.1.3 Albumedix Recombinant Human Serum Albumin Consumption, Revenue and Gross Margin (2017-2024) 55
8.1.4 Albumedix Recent Developments 55
8.2 Merck 56
8.2.1 Merck Corporation Information 56
8.2.2 Merck Recombinant Human Serum Albumin Products Offered 57
8.2.3 Merck Recombinant Human Serum Albumin Consumption, Revenue and Gross Margin (2017-2024) 57
8.2.4 Merck Recent Developments 58
8.3 Ventria (InVitria) 59
8.3.1 Ventria (InVitria) Corporation Information 59
8.3.2 Ventria (InVitria) Recombinant Human Serum Albumin Products Offered 60
8.3.3 Ventria (InVitria) Recombinant Human Serum Albumin Consumption, Revenue and Gross Margin (2017-2024) 61
8.3.4 Ventria (InVitria) Recent Developments 61
8.4 NCPC 62
8.4.1 NCPC Corporation Information 62
8.4.2 NCPC Recombinant Human Serum Albumin Products Offered 63
8.4.3 NCPC Recombinant Human Serum Albumin Consumption, Revenue and Gross Margin (2017-2024) 63
8.5 Oryzogen 64
8.5.1 Oryzogen Corporation Information 64
8.5.2 Oryzogen Recombinant Human Serum Albumin Products Offered 65
8.5.3 Oryzogen Recombinant Human Serum Albumin Consumption, Revenue and Gross Margin (2017-2024) 66
8.6 HiMedia 66
8.6.1 HiMedia Corporation Information 66
8.6.2 HiMedia Recombinant Human Serum Albumin Products Offered 67
8.6.3 HiMedia Recombinant Human Serum Albumin Consumption, Revenue and Gross Margin (2017-2024) 68
9 Marketing Channel, Distributors and Customers 69
9.1 Marketing Channel 69
9.1.1 Direct Channels 69
9.1.2 Indirect Channels 69
9.2 Recombinant Human Serum Albumin Distributors List 71
9.3 Recombinant Human Serum Albumin Customers 73
9.3.1 Thermo Fisher 75
9.3.2 STEMCELL Technologies 76
9.3.3 Merck Millipore 77
9.3.4 Lonza 78
9.3.5 Miltenyi Biotec 79
9.3.6 GSK 80
9.3.7 Merck 81
9.3.8 Sanofi 82
9.3.9 Changchun Institute of Biological 83
10 Recombinant Human Serum Albumin Market Dynamics 85
10.1 Recombinant Human Serum Albumin Industry Trends 85
10.2 Recombinant Human Serum Albumin Market Drivers 85
10.3 Recombinant Human Serum Albumin Market Challenges 86
10.4 Recombinant Human Serum Albumin Market Restraints 86
10.5 Porter's Five Forces Analysis 87
11 Conclusion 88
12 Appendix 90
12.1 Methodology/Research Approach 90
12.1.1 Research Programs/Design 90
12.1.2 Market Size Estimation 91
12.1.3 Market Breakdown and Data Triangulation 92
12.2 Data Source 93
12.2.1 Secondary Sources 93
12.2.2 Primary Sources 94
12.3 Author Details 96
12.4 Disclaimer 98